Hydrochloric Acid

Hydrochloric Acid

SCHEMBL766321

CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[Si](O)(O)O.[Cl-]

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.62
DNM1 Q05193 10/20 0.60
LMNA P02545 1/20 0.58
KMT2A Q03164 1/20 0.52
HSP90AA1 P07900 2/20 0.52
RAD52 P43351 2/20 0.52
PLA2G1B P04054 1/20 0.52
ATG4B Q9Y4P1 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30634823 0.98 HTT (0.60) HTTDNM1LMNAKMT2AHSP90AA1
Hydrochloric Acid SCHEMBL30634824 0.98 HTT (0.60) HTTDNM1LMNAKMT2AHSP90AA1
Hydrochloric Acid SCHEMBL30634825 0.98 HTT (0.60) HTTDNM1LMNAKMT2AHSP90AA1
SCHEMBL2715248 0.98 HTT (0.65) HTTDNM1LMNAKMT2AHSP90AA1
SCHEMBL17256642 0.98 HTT (0.65) HTTDNM1LMNAKMT2AHSP90AA1
Hydrochloric Acid SCHEMBL23589411 0.96 HTT (0.58) HTTDNM1LMNAKMT2AHSP90AA1
Iodide SCHEMBL22263021 0.96 HTT (0.62) HTTDNM1LMNAKMT2AHSP90AA1
Bromide SCHEMBL22263174 0.96 DNM1 (0.64) HTTDNM1LMNAKMT2AHSP90AA1
Iodide SCHEMBL29205873 0.96 HTT (0.62) HTTDNM1LMNAKMT2AHSP90AA1
Hydrochloric Acid SCHEMBL26634590 0.94 HTT (0.60) HTTDNM1LMNAKMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 663 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589173-B2 Sterilization methods for sterilizing a surgical instrument having an antimicrobial coating PARASOL MEDICAL, LLC (US) 2026-03-31 US claimed
US-20260060247-A1 GERMICIDAL COMPOSITIONS AND WIPES AND METHODS OF MAKING Saferway Research Center, LLC (US) 2026-03-05 US claimed
US-20260060246-A1 GERMICIDAL COMPOSITIONS AND WIPES AND METHODS OF MAKING Saferway Research Center, LLC (US) 2026-03-05 US claimed
US-12565567-B2 Multifunctional smart particles SYNMATTER LLC (US) 2026-03-03 US claimed
EP-3368592-B1 COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN DOW TORAY CO LTD (JP) 2025-12-03 EP claimed
EP-3620051-B1 CLEANING COMPOSITION INCLUDING BOTH A DISINFECTANT AND A LONG-LASTING ANTIMICROBIAL COMPONENT Parasol Medical LLC (US) 2025-12-03 EP claimed
WO-2025054592-A1 FILTER MEDIA WITH MICROBIOLOGICAL REDUCTION CAPABILITIES KX TECHNOLOGIES, LLC (US) 2025-03-13 WO claimed
US-12240636-B2 Method and device for storing a hypochlorous acid solution PARASOL MEDICAL, LLC (US) 2025-03-04 US claimed
US-20240390402-A1 COMPOSITION HYBRISAN LTD. (GB) 2024-11-28 US claimed
US-20240365788-A1 STABILIZED HYPOCHLOROUS ACID SOLUTION AND METHOD FOR STABILIZING HYPOCHLOROUS ACID FOR LONGER SHELF LIFE Parasol Medical LLC (US) 2024-11-07 US claimed
EP-1678266-A2 A CLEANING AND MULTIFUNCTIONAL COATING COMPOSITION CONTAINING AN ORGANOSILANE QUATERNARY COMPOUND AND METHODS OF USING Resource Development L.L.C. (US) 2006-07-12 EP claimed
US-20060110348-A1 Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using RESOURCE DEVELOPMENT L.L.C. 2006-05-25 US claimed
US-6994890-B2 Cleaning and multifunctional coating composition containing an organosilane quaternary compound and hydrogen peroxide RESOURCE DEVELOPMENT L.L.C. (US) 2006-02-07 US claimed
WO-2005042657-A2 A CLEANING AND MULTIFUNCTIONAL COATING COMPOSITION CONTAINING AN ORGANOSILANE QUATERNARY COMPOUND AND METHODS OF USING RESOURCE DEVELOPMENT L.L.C. (US) 2005-05-12 WO claimed
US-20050096250-A1 Cleaning and multifunctional coating composition containing an organosilane quaternary compound and methods of using RESOURCE DEVELOPMENT L.L.C. (US) 2005-05-05 US claimed
US-6632805-B1 With polyol containing at least three hydroxy groups and is not hydroxyethyl cellulose; treating food or medical articles EMORY UNIVERSITY 2003-10-14 US claimed
EP-0853482-A4 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE UNIV EMORY (US) 2002-07-31 EP claimed
EP-0853482-A1 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE EMORY UNIVERSITY (US) 1998-07-22 EP claimed
WO-1997042200-A1 WATER-STABILIZED ORGANOSILANE COMPOUNDS AND METHODS FOR USING THE SAME BIOSHIELD TECHNOLOGIES, INC. (US) 1997-11-13 WO claimed
WO-1997041876-A1 WATER-STABILIZED ORGANOSILANES AND METHODS FOR USE EMORY UNIVERSITY (US) 1997-11-13 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565567-B2 Multifunctional smart particles KCNN3, KCNN1, KCNN2 HTT 4245/4885DNM1 570/4885LMNA 2914/4885
US-12589173-B2 Sterilization methods for sterilizing a surgical instrument having an antimicrobial coating STS, EEF1D, SEM1 HTT 3950/4885DNM1 571/4885LMNA 3255/4885
US-20060110348-A1 Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using CUTA, MPO, CAT HTT 866/4885DNM1 1717/4885LMNA 4694/4885
US-20260060246-A1 GERMICIDAL COMPOSITIONS AND WIPES AND METHODS OF MAKING ALPG, PIK3C3, CAT HTT 2217/4885DNM1 108/4885LMNA 2212/4885
US-20260060247-A1 GERMICIDAL COMPOSITIONS AND WIPES AND METHODS OF MAKING ALPG, ACR, PIK3C3 HTT 1789/4885DNM1 423/4885LMNA 1947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.